Edessy Stem Cell Score (ESS), Endometrium, Endometrioma
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
Inclusion Criteria
- 20 to 40 years and did not receive hormonal treatment for three month
- 20 to 40 years and did not receive hormonal treatment for three month
Exclusion Criteria
- Diabetes mellitus, cardiovascular and kidney diseases, adenomyosis, Uterine fibroid Endometrial carcinoma and Poly cystic ovary
- Diabetes mellitus, cardiovascular and kidney diseases, adenomyosis, Uterine fibroid Endometrial carcinoma and Poly cystic ovary
Summary
- Conditions
- Endometriosis, Ovarian
- Type
- Interventional
- Design
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
Participation Requirements
- Age
- Between 20 years and 40 years
- Gender
- Only females
Description
This study was conducted on 40 women at Al-Azhar University Hospitals. They are divided into two equal groups, group 1 with ovarian endometrioma and group 2 with normal ovary. Ovarian and endometrial samples were evaluated by hematoxlin & eosin for histopathology (HP) and of oct-4 for immunohistoche...
This study was conducted on 40 women at Al-Azhar University Hospitals. They are divided into two equal groups, group 1 with ovarian endometrioma and group 2 with normal ovary. Ovarian and endometrial samples were evaluated by hematoxlin & eosin for histopathology (HP) and of oct-4 for immunohistochemistry (IH) for SCE. Evaluation of IH parameters revealed that the most important factors for evaluating SC were arranged as score ( Edessy Stem Cell Score=ESS).
Inclusion Criteria
- 20 to 40 years and did not receive hormonal treatment for three month
- 20 to 40 years and did not receive hormonal treatment for three month
Exclusion Criteria
- Diabetes mellitus, cardiovascular and kidney diseases, adenomyosis, Uterine fibroid Endometrial carcinoma and Poly cystic ovary
- Diabetes mellitus, cardiovascular and kidney diseases, adenomyosis, Uterine fibroid Endometrial carcinoma and Poly cystic ovary
Tracking Information
- NCT #
- NCT02103452
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mahmoud Edessy, MD Al-Azhar University Study Director: Hala hosni, MD Cairo University Study Director: Magdy Olama, MD Al-Azhar University Study Chair: Mohammad A Sattar, MD Al-Azhar University Study Chair: Ahmad Monir, MSc Al-Azhar University
- Mahmoud Edessy, MD Al-Azhar University Study Director: Hala hosni, MD Cairo University Study Director: Magdy Olama, MD Al-Azhar University Study Chair: Mohammad A Sattar, MD Al-Azhar University Study Chair: Ahmad Monir, MSc Al-Azhar University
Get Well Soon